Back to News
Market Impact: 0.05
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Source: zacks.com
Healthcare & Biotech
First Trust NYSE Arca Biotechnology ETF (FBT), a smart-beta ETF launched on June 19, 2006, provides broad exposure to the healthcare and biotechnology ETF category. The article contains no new performance, holdings, flow, or strategy information likely to affect markets.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Apollo in talks to buy J&J orthopedics unit for nearly $20 billion
- Apollo Global in talks to acquire J&J’s orthopedics unit, Bloomberg News reports
- Scholar Rock Announces FDA Approval of ISEMBYLD™ (apitegromab-mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (SMA)
- Federal budget deficit reaches $2T in first 11 months of fiscal year 2026, CBO reports
- Meet Ottava, J&J's surgical robot leading the healthcare giant into a lucrative new market
- AstraZeneca breast cancer drug fails late-stage trial goal